Research Catalog

Title

Guidance for industry : minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies.

Publication

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

Details

Additional Authors

Center for Biologics Evaluation and Research (U.S.)

Description

ii, 46 pages : digital, PDF file

Alternative Title

Minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies

Subject

• Fetal blood
• Hematopoiesis
• Hematoma
• Blood banks > Licenses > United States

Note

• Title from PDF title page (viewed on May 11, 2009).
• "Draft guidance."
• "December 2006".

Bibliography (note)

• Includes bibliographical references (page 46).

System Details (note)

• Mode of access: Internet at the FDA CBER web site. Address as of 5/11/09: http://www.fda.gov/cber/gdlns/cordbld.pdf ; current access is available via PURL.

Call Number

GPO Internet HE 20.4802:C 81/2

OCLC

marcive320778975

Title

Guidance for industry : minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies.

Publisher

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

Type of Content

text

Type of Medium

computer

Type of Carrier

online resource

System Details

Mode of access: Internet at the FDA CBER web site. Address as of 5/11/09: http://www.fda.gov/cber/gdlns/cordbld.pdf ; current access is available via PURL.

Bibliography

Includes bibliographical references (page 46).

Connect to:

https://purl.fdlp.gov/GPO/LPS112475

Added Author

Center for Biologics Evaluation and Research (U.S.)

Gpo Item No.

0499-T-02 (online)

Sudoc No.

HE 20.4802:C 81/2